Answers are grounded in this paper and cite their sources.
Novel peptide SMIM45-107aa enhances HCC progression, suggesting therapeutic strategy for cancer treatment.
We identified SMIM45-107aa, a novel peptide encoded by LINC00634, which promoted HCC progression via the MGST1-pAKT-MTDH axis. The derived peptide 5 exhibited anticancer activity, suggesting a potential therapeutic strategy for HCC.
No takes yet. Share an insight, caveat, or question.
An et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: